Bisphosphonate-associated osteonecrosis of the jaws
- 1 October 2005
- journal article
- Published by Elsevier BV in Journal of Oral and Maxillofacial Surgery
- Vol. 63 (10), 1555-1556
- https://doi.org/10.1016/j.joms.2005.06.003
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Osteonecrosis and bisphosphonates: correlation versus causationJournal of Oral and Maxillofacial Surgery, 2004
- Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 casesJournal of Oral and Maxillofacial Surgery, 2004
- Bisphosphanates and Oral Cavity Avascular Bone NecrosisJournal of Clinical Oncology, 2003
- Avascular necrosis of the jaws: risk factors in metastatic cancer patientsJournal of Oral and Maxillofacial Surgery, 2003
- Zoledronic acid for the treatment of bone metastases in patients with breast cancer and other solid tumorsSeminars in Oncology, 2003
- Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemicJournal of Oral and Maxillofacial Surgery, 2003
- Metastatic bone disease: clinical features, pathophysiology and treatment strategiesCancer Treatment Reviews, 2001
- Osteoporosis Due to Cancer Treatment: Pathogenesis and ManagementJournal of Clinical Oncology, 2000
- Mortality after all major types of osteoporotic fracture in men and women: an observational studyThe Lancet, 1999
- Comparative Tolerability of Drug Therapies for Hypercalcaemia of MalignancyDrug Safety, 1999